Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-888711 in relapsed persistent or chronic immune thrombocytopenia
2009-016950-42Phase 2Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lusutrombopag in immune thrombocytopenia (ITP) and chronic thrombocytopenia (4 arms), sponsored by Shionogi & Co., Ltd. Primary endpoints: Platelet count and Bleeding evaluation. Started Mar 2010; status: completed.
02
Drugs
lusutrombopag
03
Conditions
immune thrombocytopenia (ITP)chronic thrombocytopenia
Beyond the preview
Go deeper on 2009-016950-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016950-42.